Medication preventing postictal hypoperfusion and cognitive side-effects in electroconvulsive therapy: A retrospective cohort study

BackgroundElectroconvulsive therapy (ECT) is associated with postictal confusion and cognitive side-effects. In rats, acetaminophen, non-steroidal anti-inflammatory drugs (NSAIDs) and calcium antagonists decreased postictal cerebral hypoperfusion along with reduction in postictal symptoms. In this s...

Full description

Bibliographic Details
Main Authors: Joey P. A. J. Verdijk, Gijsbert Schuur, Julia C. M. Pottkämper, Freek ten Doesschate, Jeannette Hofmeijer, Jeroen A. van Waarde
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Psychiatry
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1026014/full
_version_ 1828038337296859136
author Joey P. A. J. Verdijk
Joey P. A. J. Verdijk
Gijsbert Schuur
Julia C. M. Pottkämper
Julia C. M. Pottkämper
Freek ten Doesschate
Jeannette Hofmeijer
Jeannette Hofmeijer
Jeroen A. van Waarde
author_facet Joey P. A. J. Verdijk
Joey P. A. J. Verdijk
Gijsbert Schuur
Julia C. M. Pottkämper
Julia C. M. Pottkämper
Freek ten Doesschate
Jeannette Hofmeijer
Jeannette Hofmeijer
Jeroen A. van Waarde
author_sort Joey P. A. J. Verdijk
collection DOAJ
description BackgroundElectroconvulsive therapy (ECT) is associated with postictal confusion and cognitive side-effects. In rats, acetaminophen, non-steroidal anti-inflammatory drugs (NSAIDs) and calcium antagonists decreased postictal cerebral hypoperfusion along with reduction in postictal symptoms. In this study, in ECT-patients, we explore associations between use of these potentially protective medications and occurrence of postictal confusion and cognitive outcome.Materials and methodsIn this retrospective, naturalistic cohort study, patient-, treatment-, and ECT-characteristics, were collected from medical files of patients treated with ECT for major depressive disorder (MDD) or bipolar depressive episode. To test for associations of use of these medications with occurrence of postictal confusion, 295 patients could be included. Cognitive outcome data were available in a subset of 109 patients. Univariate analyses and multivariate censored regression models were used to test for associations.ResultsOccurrence of severe postictal confusion was not associated with use of acetaminophen, NSAIDs or calcium antagonists (n = 295). Regarding the cognitive outcome measure (n = 109), use of calcium antagonists was associated with higher post-ECT cognitive scores (i.e., better cognitive outcome; β = 2.23; p = 0.047), adjusted for age (β = −0.02; p = 0.23), sex (β = −0.21; p = 0.73), pre-ECT cognitive score (β = 0.47; p < 0.0001), and post-ECT depression score (β = −0.02; p = 0.62), but use of acetaminophen (β = −1.55; p = 0.07) as well as NSAIDs (β = −1.02; p = 0.23) showed no associations.ConclusionThis retrospective study does not find arguments for protective effects of acetaminophen, NSAIDs or calcium antagonists against severe postictal confusion in ECT. As a preliminary finding, the use of calcium antagonists was associated with improved cognitive outcome after ECT in this cohort. Prospective controlled studies are necessary.
first_indexed 2024-04-10T16:25:31Z
format Article
id doaj.art-2597aeffd91c42548a9df24b986d7b2a
institution Directory Open Access Journal
issn 1664-0640
language English
last_indexed 2024-04-10T16:25:31Z
publishDate 2023-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Psychiatry
spelling doaj.art-2597aeffd91c42548a9df24b986d7b2a2023-02-09T06:32:39ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402023-02-011410.3389/fpsyt.2023.10260141026014Medication preventing postictal hypoperfusion and cognitive side-effects in electroconvulsive therapy: A retrospective cohort studyJoey P. A. J. Verdijk0Joey P. A. J. Verdijk1Gijsbert Schuur2Julia C. M. Pottkämper3Julia C. M. Pottkämper4Freek ten Doesschate5Jeannette Hofmeijer6Jeannette Hofmeijer7Jeroen A. van Waarde8Department of Psychiatry, Rijnstate Hospital, Arnhem, NetherlandsDepartment of Clinical Neurophysiology, TechMed Centre, University of Twente, Enschede, NetherlandsDepartment of Psychiatry, Rijnstate Hospital, Arnhem, NetherlandsDepartment of Psychiatry, Rijnstate Hospital, Arnhem, NetherlandsDepartment of Clinical Neurophysiology, TechMed Centre, University of Twente, Enschede, NetherlandsDepartment of Psychiatry, Rijnstate Hospital, Arnhem, NetherlandsDepartment of Clinical Neurophysiology, TechMed Centre, University of Twente, Enschede, NetherlandsDepartment of Neurology, Rijnstate Hospital, Arnhem, NetherlandsDepartment of Psychiatry, Rijnstate Hospital, Arnhem, NetherlandsBackgroundElectroconvulsive therapy (ECT) is associated with postictal confusion and cognitive side-effects. In rats, acetaminophen, non-steroidal anti-inflammatory drugs (NSAIDs) and calcium antagonists decreased postictal cerebral hypoperfusion along with reduction in postictal symptoms. In this study, in ECT-patients, we explore associations between use of these potentially protective medications and occurrence of postictal confusion and cognitive outcome.Materials and methodsIn this retrospective, naturalistic cohort study, patient-, treatment-, and ECT-characteristics, were collected from medical files of patients treated with ECT for major depressive disorder (MDD) or bipolar depressive episode. To test for associations of use of these medications with occurrence of postictal confusion, 295 patients could be included. Cognitive outcome data were available in a subset of 109 patients. Univariate analyses and multivariate censored regression models were used to test for associations.ResultsOccurrence of severe postictal confusion was not associated with use of acetaminophen, NSAIDs or calcium antagonists (n = 295). Regarding the cognitive outcome measure (n = 109), use of calcium antagonists was associated with higher post-ECT cognitive scores (i.e., better cognitive outcome; β = 2.23; p = 0.047), adjusted for age (β = −0.02; p = 0.23), sex (β = −0.21; p = 0.73), pre-ECT cognitive score (β = 0.47; p < 0.0001), and post-ECT depression score (β = −0.02; p = 0.62), but use of acetaminophen (β = −1.55; p = 0.07) as well as NSAIDs (β = −1.02; p = 0.23) showed no associations.ConclusionThis retrospective study does not find arguments for protective effects of acetaminophen, NSAIDs or calcium antagonists against severe postictal confusion in ECT. As a preliminary finding, the use of calcium antagonists was associated with improved cognitive outcome after ECT in this cohort. Prospective controlled studies are necessary.https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1026014/fullelectroconvulsive therapyacetaminophennon-steroidal anti-inflammatory drugscalcium antagonistscognitive outcome
spellingShingle Joey P. A. J. Verdijk
Joey P. A. J. Verdijk
Gijsbert Schuur
Julia C. M. Pottkämper
Julia C. M. Pottkämper
Freek ten Doesschate
Jeannette Hofmeijer
Jeannette Hofmeijer
Jeroen A. van Waarde
Medication preventing postictal hypoperfusion and cognitive side-effects in electroconvulsive therapy: A retrospective cohort study
Frontiers in Psychiatry
electroconvulsive therapy
acetaminophen
non-steroidal anti-inflammatory drugs
calcium antagonists
cognitive outcome
title Medication preventing postictal hypoperfusion and cognitive side-effects in electroconvulsive therapy: A retrospective cohort study
title_full Medication preventing postictal hypoperfusion and cognitive side-effects in electroconvulsive therapy: A retrospective cohort study
title_fullStr Medication preventing postictal hypoperfusion and cognitive side-effects in electroconvulsive therapy: A retrospective cohort study
title_full_unstemmed Medication preventing postictal hypoperfusion and cognitive side-effects in electroconvulsive therapy: A retrospective cohort study
title_short Medication preventing postictal hypoperfusion and cognitive side-effects in electroconvulsive therapy: A retrospective cohort study
title_sort medication preventing postictal hypoperfusion and cognitive side effects in electroconvulsive therapy a retrospective cohort study
topic electroconvulsive therapy
acetaminophen
non-steroidal anti-inflammatory drugs
calcium antagonists
cognitive outcome
url https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1026014/full
work_keys_str_mv AT joeypajverdijk medicationpreventingpostictalhypoperfusionandcognitivesideeffectsinelectroconvulsivetherapyaretrospectivecohortstudy
AT joeypajverdijk medicationpreventingpostictalhypoperfusionandcognitivesideeffectsinelectroconvulsivetherapyaretrospectivecohortstudy
AT gijsbertschuur medicationpreventingpostictalhypoperfusionandcognitivesideeffectsinelectroconvulsivetherapyaretrospectivecohortstudy
AT juliacmpottkamper medicationpreventingpostictalhypoperfusionandcognitivesideeffectsinelectroconvulsivetherapyaretrospectivecohortstudy
AT juliacmpottkamper medicationpreventingpostictalhypoperfusionandcognitivesideeffectsinelectroconvulsivetherapyaretrospectivecohortstudy
AT freektendoesschate medicationpreventingpostictalhypoperfusionandcognitivesideeffectsinelectroconvulsivetherapyaretrospectivecohortstudy
AT jeannettehofmeijer medicationpreventingpostictalhypoperfusionandcognitivesideeffectsinelectroconvulsivetherapyaretrospectivecohortstudy
AT jeannettehofmeijer medicationpreventingpostictalhypoperfusionandcognitivesideeffectsinelectroconvulsivetherapyaretrospectivecohortstudy
AT jeroenavanwaarde medicationpreventingpostictalhypoperfusionandcognitivesideeffectsinelectroconvulsivetherapyaretrospectivecohortstudy